Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-12-09A Phase 1, Partially-Blinded, Placebo-Controlled, Randomized, Single Ascending Dose (SAD) With a Food Effect Cohort Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adult Participants.
-
CLINICAL_TRIALS study record update · 2024-12-05A Single-Center, Open Label Study to Investigate the Mass Balance, Excretion Pathways and Metabolites After a Single Oral Dose of 500 MG, 3.7 MBq, [14C]BTZ-043 in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2024-12-04TuBerculosis Incidence in AS, PsA or Pso Patients Treated With Secukinumab: Real World Evidence in Brazilian Environment (ToBeReal)
-
CLINICAL_TRIALS study record update · 2024-11-29Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
-
CLINICAL_TRIALS study record update · 2024-11-29Implementing a Systemic Screening for TB Disease in High-risk Groups in Barcelona Area
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-11-27Evaluating the Potential of Large Language Models for Respiratory Disease Consultations: A Randomized Crossover Trial
-
CLINICAL_TRIALS study record update · 2024-11-25Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
-
CLINICAL_TRIALS study record update · 2024-11-22Prevalence of Multidrug Resistant Tuberculosis by Xpert MTB/RIF Ultra and Xpert XDR Assay Among Newly Diagnosed Cases
-
CLINICAL_TRIALS study record update · 2024-10-23Using Short Message Service Reminders, Phone Calls and Mobile Money Incentives to Enhance Linkage to Care of Presumptive Tuberculosis Patients in Uganda: a Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-10-16Whole Genome Sequencing of Tuberculosis for Disease Control in Madagascar - a Cluster Randomized Controlled Trial to Evaluate Different Community-wide Intervention Strategies.
-
CLINICAL_TRIALS study record update · 2024-10-10Exploring the Role of Microbiome in Susceptibility, Treatment Response and Outcome Among Tuberculosis Patients; a Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2024-10-08A Phase 1, Drug-Drug Interaction Study to Evaluate the Safety, Tolerability, and the Induction Potential of TBAJ-876 on CYP3A4 and P-glycoprotein and the Inhibition Potential of TBAJ-876 on P-glycoprotein in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2024-10-01Two-site Laboratory-based Diagnostic Accuracy and Feasibility Study of the Xpert MTB/XDR Assay for Detection of Isoniazid, Fluoroquinolone, Ethionamide and Second-line Injectable Anti-tuberculosis Drug Resistance
-
CLINICAL_TRIALS study record update · 2024-10-01Study on the Safety of Administering Isoniazid to Systemic Lupus Erythematosus Patients to Prevent Tuberculosis
-
CLINICAL_TRIALS study record update · 2024-09-26Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
-
CLINICAL_TRIALS study record update · 2024-09-26Detection of Lipoarabinomannan in Urine, Evaluation of the STANDARDTM F TB LAM FIA and Its Impact on the Initial Diagnosis of TB
-
CLINICAL_TRIALS study record update · 2024-09-19Evaluation and Validation of Novel Immunodiagnostic Tests for Childhood Tuberculosis Infection and Disease in Switzerland. The CITRUS (ChIldhood TubeRcUlosis in Switzerland) Study.
-
CLINICAL_TRIALS study record update · 2024-09-19An Open-Label Phase 2 Trial to Evaluate the Male Reproductive Safety of a 6-Month Combination Treatment for Pulmonary Tuberculosis (TB) of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) in Adult Male Participants With Drug Resistant Pulmonary TB
-
CLINICAL_TRIALS study record update · 2024-09-04Effect of Endurance Training On Functional Capacity and Quality of Life in Patients With Post-TB Lung Disease
-
CLINICAL_TRIALS study record update · 2024-08-30The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis From Healthy Blood Donors and Patients With Latent or Active Tuberculosis.
-
CLINICAL_TRIALS study record update · 2024-08-29Efficacy and Safety of an Initial Regimen Raltegravir (RAL) + Lamivudine/Abacavir Fixed-Dose Combination (3TC/ABC FDC) for 48 Weeks in ART- naïve, HIV/TB Co-Infected Adult Subjects Receiving Rifabutin-containing, 1-line Anti-TB Therapy
-
CLINICAL_TRIALS study record update · 2024-08-28An Open Label, Randomized Controlled Trial to Establish the Efficacy and Safety of a Study Strategy Consisting of 6 Months of Bedaquiline (BDQ), Delamanid (DLM), and Linezolid (LNZ), With Levofloxacin (LVX) and Clofazimine (CFZ) Compared to the Current South African Standard of Care (Control Strategy) for 9 Months for the Treatment of Rifampicin Resistant Tuberculosis (RR-TB)
-
CLINICAL_TRIALS study record update · 2024-08-23Comparing Gene Expression Profiles of Adults With Isolated Spinal TB to Disseminated Spinal TB Identified by 18FDG-PET/CT at Time of Diagnosis, 6-and 12-months Follow-up
-
CLINICAL_TRIALS study record update · 2024-08-21Frequency of Tuberculosis in Psoriasis Patients Using Anti-TNF Therapy During 15 Years of Follow-up.
-
CLINICAL_TRIALS study record update · 2024-08-13Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin